Servier is Top Employer Europe for the 3rd consecutive year!
All the news from Servier Group
Servier and Aqemia extend collaboration on undruggable target in immuno-oncology
FederAidd: An international virtual campus to accelerate therapeutic discovery
Servier partners with Gustave Roussy to develop research programs in oncology
Our commitment for Ukraine
ACTNOWFORDIABETES: Let’s focus on therapeutic adherence
Saclay-Boston Biotech Masterclass Season 2: 7 French start-up are going all-in to discover the paragon of US HealthTech!
Servier at ASH meeting to present new data in hematology research
Primary Sjögren’s syndrome: completion of patient enrollment in Phase 2a clinical trial